| Scott Michael Luneau, MD | |
|
15 Regional Dr, Pinehurst, NC 28374-8850 | |
| (910) 295-5511 | |
| (910) 420-1616 |
| Full Name | Scott Michael Luneau |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 15 Regional Dr, Pinehurst, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972665529 | NPI | - | NPPES |
| 9043508 | Other | NC | AETNA |
| N0127B | Medicaid | SC | |
| 153X5 | Other | NC | BC/BS NC |
| 1972665529 | Medicaid | NC | |
| FH1100760 | Other | NC | FIRSTCAROLINACARE INSURANCE CO |
| 5912479 | Medicaid | NC | |
| NO127B | Other | SC | SC MEDICAID |
| P01296912 | Other | NC | PALMETTO GBA RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Liberty Home Care | Southern pines, NC | Home health agency |
| Firsthealth Hospice | West end, NC | Hospice |
| Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinehurst Medical Clinic Inc | 5991617169 | 159 |
News Archive
A multidisciplinary research team led by University of Houston scientist Jarek Wosik has developed a high-temperature superconducting coil that allows magnetic resonance imaging (MRI) scanners to produce higher resolution images or acquire images in a shorter time than when using conventional coils.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.
› Verified 9 days ago
| Entity Name | Pinehurst Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255388369 PECOS PAC ID: 5991617169 Enrollment ID: O20031105000305 |
News Archive
A multidisciplinary research team led by University of Houston scientist Jarek Wosik has developed a high-temperature superconducting coil that allows magnetic resonance imaging (MRI) scanners to produce higher resolution images or acquire images in a shorter time than when using conventional coils.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.
› Verified 9 days ago
| Entity Name | Scotland Regional Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972829562 PECOS PAC ID: 2365573185 Enrollment ID: O20100623000242 |
News Archive
A multidisciplinary research team led by University of Houston scientist Jarek Wosik has developed a high-temperature superconducting coil that allows magnetic resonance imaging (MRI) scanners to produce higher resolution images or acquire images in a shorter time than when using conventional coils.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Michael Luneau, MD 205 Page Rd, Pinehurst, NC 28374-8749 Ph: (910) 295-5511 | Scott Michael Luneau, MD 15 Regional Dr, Pinehurst, NC 28374-8850 Ph: (910) 295-5511 |
News Archive
A multidisciplinary research team led by University of Houston scientist Jarek Wosik has developed a high-temperature superconducting coil that allows magnetic resonance imaging (MRI) scanners to produce higher resolution images or acquire images in a shorter time than when using conventional coils.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.
› Verified 9 days ago
Michael A Pritchett, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Page Road, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3401 | |
Bobby R Maynor Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-255-4400 Fax: 910-420-1604 | |
Francis Farrell Collins Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3419 | |
Kristina Maria Catania, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-7984 | |
Dr. Scott D Skibo, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 102-955-5119 Fax: 910-235-3421 | |
David F Martin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-295-9207 Fax: 910-235-3432 | |
Charles Samuel Kuzma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Page Rd, Pinehurst, NC 28374 Phone: 910-715-3500 Fax: 910-715-3501 |